Personalized Support Boosted Cancer Genetic Testing
Facilitated navigation significantly increased genetic testing rates among relatives of cancer patients.
Updated on Oct. 9, 2026 in Cancer
Live Poll
If a family history of cancer existed, would you complete recommended genetic testing?
A study published in the Journal of Clinical Oncology found that personalized support helped relatives of cancer patients undergo genetic testing. The intervention led to a 73.2 percent uptake rate at six months, compared to 50.7 percent for those receiving standard care.
Why it matters
Informing relatives about inherited cancer risk is often insufficient to ensure they seek necessary testing. This navigation-based approach provides a practical solution to bridge the gap between risk awareness and clinical action.
In a study of 151 probands, 90 percent of relatives in the intervention group completed testing by 18 months. Among 206 relatives who finished testing, 46 percent carried a pathogenic variant, with 86 percent of those carrying the specific familial variant.
The players
MD Anderson Cancer Center
This Houston-based institution is a leading global center for cancer patient care, research, education, and prevention.
The details
Researchers at MD Anderson Cancer Center in Houston randomly assigned 151 probands with newly diagnosed BRCA1/2 pathogenic variants to either standard care or facilitated cascade genetic testing. The intervention group received dedicated navigation support to guide them through the testing process.
Timeline
September 29, 2026: The study was published in the Journal of Clinical Oncology.
6 months: Researchers measured the initial difference in testing uptake between study groups.
18 months: The intervention group achieved a 90 percent testing completion rate.
Health Landscape
This study conducted at the MD Anderson Cancer Center updates current protocols for hereditary cancer screening by demonstrating the efficacy of navigation support. It marks a shift from relying on patient initiative to utilizing active professional guidance to manage hereditary risks.
This research suggests that relatives of cancer patients should inquire about clinical navigation services to simplify the genetic testing process. Early testing remains the most effective way to identify pathogenic variants and implement preventative health measures.
The takeaway
Proactive support systems are essential for ensuring that family members at high risk for cancer follow through with genetic testing. Patients and their families should prioritize clear communication with medical teams to access these valuable testing resources.
Further reading
For more on the latest research in hereditary risks and screening, visit our Cancer section.
Source note: This article includes information reported by Healthday.
Live Poll
If a family history of cancer existed, would you complete recommended genetic testing?
